July 13, 2012

Nearly 200 drugs for mental illnesses are under clinical development or under review by the Food and Drug Administration, the largest lobbying group for the drug industry said Thursday.

March 19, 2012

Women take mental health drugs at a much higher rate than men, according to a new study by one of the country's largest pharmacy benefit managers.

February 28, 2012

Lowering health costs will require a greater understanding of differences between two distinct groups of patients, according to a new study, which also noted a growing availability of specialty drugs for complex and chronic conditions outside the hospital.

July 7, 2011

Preventive health care may be signficiantly less costly than previously thought because of the expanded use of cost-effective generic medications for the treatment and prevention of chronic diseases, according to researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.

February 1, 2011

MISSISSAUGA, Ontario — As CEO of Katz Group Canada and its flagship Rexall chain, Andy Giancamilli has spearheaded a transformation of the company’s approach to drug store retailing and health-and-wellness merchandising. That renewal has spawned a new Rexall prototype store and a new approach to customer segmentation.


August 12, 2010

The companies working on more than half of the mental illness drugs under development are...

January 10, 2010

Novartis has launched a new drug for treating schizophrenia in the United States, the Swiss...